Advertisement
Home 2016

Archives

More than half of health professionals view improved health insurance coverage as a solution for obesity management and weight loss

Health Professionals View Insurance As Solution in Obesity

0
Fifty-seven percent perceive improved coverage as a solution to improve outcomes in obese patients
Three injections of a therapeutic vaccine may control herpes simplex virus 2 as effectively as daily pills for at least a year

ISDA: Vaccine Might Help Prevent HSV-2 Transmission

0
Three-dose regimen seems as effective as daily pills, but more research needed
Many patients with obesity

Many Obese Patients Are Lacking Formal Diagnosis

0
Less than 50 percent of those with a BMI >30 kg/m² have ICD-9 documentation for obesity
College athletes report less than 1 percent of symptoms captured with a smartphone-based ecological momentary assessment to sports medicine clinicians

College Athletes Report Few Symptoms to Doctors

0
Report less than 1 percent of symptoms ID'd by smartphone-based ecologic momentary assessment
For the treatment of adults with complicated urinary tract infections

IDSA: New Treatment Offers Promise for Complicated UTIs

0
Meropenem-vaborbactam effective against carbapenem-resistant Enterobacteriaceae
For patients with left main coronary artery disease

PCI Noninferior to CABG for Left Main Coronary Artery Disease

0
PCI with everolimus-eluting stent noninferior for composite of death, stroke, or MI at three years
There is no significant difference in the presence of bacteriuria plus pyuria over one year among older women living in nursing homes receiving cranberry capsules versus a placebo pill

IDSA: Cranberry Capsules Don’t Appear to Help Prevent UTIs

0
In female nursing home residents, no significant effect on bacteriuria plus pyuria over one year
The estimated prevalence of current immunosuppression is 2.7 percent among the U.S. population

ISDA: U.S. Prevalence of Immunosuppression 2.7 Percent

0
Prevalence ranged from 1.8 to 3.1 percent; highest among women, whites, those aged 50 to 59 years
The intravenous drug ibalizumab might revolutionize the treatment of HIV patients who don't respond to existing drugs

IDSA: Experimental Rx May Be Option in Drug-Resistant HIV

0
'This is potentially a lifesaving therapy,' researcher says
Subacute sclerosing panencephalitis

IDSA: Measles Complication SSPE More Common Than Thought

0
Clinicians to be aware of subacute sclerosing panencephalitis